We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Recommendations Issued for Endocrine Hypertension Screening

By LabMedica International staff writers
Posted on 19 Apr 2017
A new Scientific Statement offers guidance to healthcare providers on ways to identify underlying hormonal causes of high blood pressure, particularly conditions that can be cured with surgery or treated effectively with medication.

The Scientific Statement was issued by the Endocrine Society (Washington, DC, USA) as a resource to improve detection of curable forms of hypertension. Without effective screening, common hormonal causes of high blood pressure often go undiagnosed and untreated. This can leave individuals with these conditions at greater risk of developing cardiovascular or renal disease.

“Without appropriate lab tests, some common endocrine disorders are nearly indistinguishable from a routine case of hypertension,” said William F. Young, Jr, MD, MSc, of Mayo Clinic (Rochester, MN, USA), and chair of the task force that authored the Statement, “Screening for underlying causes of high blood pressure can save lives. This new resource offers healthcare providers valuable guidance on when to suspect a hormone disorder and how to test for it.”

Hypertension can be the first sign of any of 15 known endocrine disorders. The endocrine system produces and controls hormones. Potential causes of hypertension can include tumors that produce adrenal hormones (e.g. aldosterone and adrenaline), thyroid disorders, or acromegaly (where excess growth hormone builds up in the bloodstream), obstructive sleep apnea. The Statement advises on the screening process for, and delves into the number of people affected by, the 15 endocrine disorders.

The most common endocrine cause of hypertension is primary aldosteronism, which occurs when the adrenal glands produce too much aldosterone. The resulting buildup of aldosterone (which normally helps balance blood levels of sodium and potassium) results in excess sodium that can raise blood pressure. As many as 1 in 10 people with hypertension may have this condition, according to the Society’s Clinical Practice Guideline on management of primary aldosteronism.

“Healthcare providers should consider primary aldosteronism screening for most people who have hypertension,” said Dr. Young, “The condition can be easily treated and often cured when it is diagnosed. Early detection also reverses the elevated risk of cardiovascular events and kidney failure in this population.”

The statement, by Young WF et al, was published April 5, 2017, in the journal Endocrine Reviews.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Latest Clinical Chem. News

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases

New Blood Testing Method Detects Potent Opioids in Under Three Minutes